Thiazolidinedione usage is associated with decreased response to clopidogrel in DM patients

Int J Cardiol. 2013 Sep 20;168(1):608-10. doi: 10.1016/j.ijcard.2013.01.225. Epub 2013 Mar 24.

Authors

Kyung Woo Park¹, Jeehoon Kang, Jin Joo Park, Han-Mo Yang, Yoo-Wook Kwon, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim

Affiliation

¹ Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.

PMID: 23531377
DOI: 10.1016/j.ijcard.2013.01.225

No abstract available

Keywords: Clopidogrel; Cytochrome P450 3A enzyme; On-treatment platelet reactivity; Thiazolidinedione.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Clopidogrel
Cohort Studies
Diabetes Mellitus / blood
Diabetes Mellitus / drug therapy*
Drug Interactions / physiology
Female
Humans
Male
Middle Aged
Prospective Studies
Registries
Thiazolidinediones / blood
Thiazolidinediones / therapeutic use*
Ticlopidine / analogs & derivatives*
Ticlopidine / blood
Ticlopidine / therapeutic use
Treatment Outcome

Substances

Thiazolidinediones
Clopidogrel
2,4-thiazolidinedione
Ticlopidine